JANUS HENDERSON GROUP PLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,241,473
+22.6%
45,567
+0.0%
0.00%0.0%
Q2 2023$1,012,948
-62.8%
45,546
-63.8%
0.00%
-50.0%
Q1 2023$2,723,928
-6.1%
125,800
-11.9%
0.00%0.0%
Q4 2022$2,900,484
-73.5%
142,815
-83.3%
0.00%
-75.0%
Q3 2022$10,962,952
+202.3%
854,326
+460.2%
0.01%
+166.7%
Q2 2022$3,627,000
+24.6%
152,511
+18.0%
0.00%
+200.0%
Q1 2022$2,911,000
-16.8%
129,264
-26.8%
0.00%0.0%
Q4 2021$3,497,000
+10.1%
176,591
+9.5%
0.00%0.0%
Q3 2021$3,175,000
-24.7%
161,342
-15.8%
0.00%
-50.0%
Q2 2021$4,216,000
-19.6%
191,618
-13.0%
0.00%0.0%
Q1 2021$5,242,000
+42.4%
220,358
+56.7%
0.00%0.0%
Q4 2020$3,680,000
+76.6%
140,665
+17.5%
0.00%
+100.0%
Q3 2020$2,084,000
+26.4%
119,737
+22.1%
0.00%0.0%
Q2 2020$1,649,000
+598.7%
98,095
+393.2%
0.00%
Q1 2020$236,000
-70.6%
19,890
-70.0%
0.00%
Q4 2019$803,000
-9.2%
66,324
+6.0%
0.00%
Q3 2019$884,000
+44.9%
62,566
+14.4%
0.00%
Q2 2019$610,000
-7.3%
54,692
-2.4%
0.00%
Q1 2019$658,00056,0170.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders